Boehringer`s Survodutide Cut Fibrosis, No MASH Worsening In 64.5%
07 Jun 2024 //
GLOBENEWSWIRE
Zealand: Boehringer`s Survodutide Cut Fibrosis, No MASH Worsening
07 Jun 2024 //
GLOBENEWSWIRE
Zealand: Boehringer To Present Positive Survodutide MASH Trial At EASL
06 Jun 2024 //
GLOBENEWSWIRE
Obesity drug from Boehringer, Zealand succeeds in MASH trial
27 Feb 2024 //
BIOPHARMA DIVE